Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).

  • STATUS
    Recruiting
  • sponsor
    AKEBIA THERAPEUTICS
Updated on 25 March 2021

Summary

Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).

Description

A Multicenter, Randomized, Open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Qualified Participants will receive at no cost to them.

  • Study Medication
  • Study Related Labs
  • Physical Exams
  • Rescue Medication
  • Compensation for your time and travel for each completed study visit

    To Lean More about this study and other Chronic Kidney Disease ( CKD) for Non- Dialysis ( NDD) - including Dialysis Dependent ( DD), with or with out Anemia , please go to our contact information below.

  • Details
    Clinical Study IdentifierTX150858
    Sponsor AKEBIA THERAPEUTICS
    Last Modified on25 March 2021

    Eligibility

    Yes No Not Sure

    Inclusion Criteria

    Is your age between 18 yrs and 0 yrs?
    Gender: Male or Female
    Age 18 and above
    History of CKD ( Chronic Kidney Disease)
    History of Anemia
    NO ESA Treatment / or on ESA Treatment
    None Dialysis
    Clear my responses

    How to participate?

    Step 1 Connect with a site
    What happens next?
    • You can expect the study team to contact you via email or phone in the next few days.
    • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

    You are contacting

    Investigator Avatar
    Name

    Primary Contact

    site
    Name

    Phone Email

    0/250
    Please verify that you are not a bot.

    Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

    Learn more

    If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

    Learn more

    Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

    Learn more

    Similar trials to consider

    Loading...

    Not finding what you're looking for?

    Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

    Sign up as volunteer

    user name

    Added by • 

     • 

    Private

    Reply by • Private
    Loading...

    Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

      The passcode will expire in None.
    Loading...

    No annotations made yet

    Add a private note
    • abc Select a piece of text from the left.
    • Add notes visible only to you.
    • Send it to people through a passcode protected link.
    Add a private note